Skip to content

Application and dose study of ciprofol during induction of anesthesia for colonoscopy in patients with different body mass index

Application and dose study of ciprofol during induction of anesthesia for colonoscopy in patients with different body mass index

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079345
Enrollment
Unknown
Registered
2024-01-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonoscopy

Interventions

Sponsors

Jiangxi Provincial People's Hospital (First Affiliated Hospital of Nanchang Medical College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Age range from 18 to 80 years old, regardless of gender; ? ASA is classified as Level I or Level II; ? BMI 18.5-35kg/m2; ? No serious cardiovascular or pulmonary diseases; ? No history of allergic reactions to cyclic phenols or legumes; ? Clearly understand and voluntarily participate in the study, and have the individual or their family sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Patients who refuse or do not cooperate with anesthesia and sedation (such as those with a history of mental illness); ? Concomitant severe arrhythmia or cardiovascular disease; ? Have a history of myocardial infarction and unstable angina within the past 6 months; ? Respiratory system diseases or pulse oximetry (SpO2)<95%, no oxygen intake; ? Pregnant or lactating women; ? Known to be allergic to eggs, soy products, opioid drugs and their antidotes, propofol, and other substances; ? Participated in other drug clinical trials as a subject within 3 months; ? The researchers believe that patients should not participate in this trial.

Design outcomes

Primary

MeasureTime frame
Ciprofol induced dose;First addition interval and total number of additions;vital signs;

Secondary

MeasureTime frame
The incidence of intraoperative hypoxemia (SPO2<90%);Colonoscopy operation time and awakening time;Adverse events occur (nausea, vomiting, dizziness, restlessness, drowsiness);

Countries

CHINA

Contacts

Public ContactLI-Yaqi

Jiangxi Provincial People's Hospital (First Affiliated Hospital of Nanchang Medical College)

tfmqdoc@163.com+86 138 7087 9814

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026